SDHB mutation carriers with malignant pheochromocytoma respond better to CVD-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

SDHB mutation carriers with malignant pheochromocytoma respond better to CVD

Published:2017-08 Issue:8 Volume:24 Page:L51-L55
ISSN:1351-0088
Container-title:Endocrine-Related Cancer
language:
Short-container-title:

Author:

Fishbein L,Ben-Maimon S,Keefe S,Cengel K,Pryma D A,Loaiza-Bonilla A,Fraker D L,Nathanson K L,Cohen D L

Publisher

Bioscientifica

Subject

Cancer Research,Endocrinology,Oncology,Endocrinology, Diabetes and Metabolism

Reference20 articles.

1. Chemotherapy with cyclophosphamide, vincristine and dacarbazine for malignant paraganglioma and pheochromocytoma: systematic review and meta-analysis;Clinical Endocrinology,2014

2. Controlling tumor progression with cyclophosphamide, vincristine, and dacarbazine treatment improves survival in patients with metastatic and unresectable malignant pheochromocytomas/paragangliomas;Hormones and Cancer,2017

3. Treatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomas;Journal of Clinical Endocrinology and Metabolism,2012

4. Inherited mutations in pheochromocytoma and paraganglioma: why all patients should be offered genetic testing;Annals of Surgical Oncology,2013

5. Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status.;European Journal of Cancer,2012

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent progress in molecular classification of phaeochromocytoma and paraganglioma;Best Practice & Research Clinical Endocrinology & Metabolism;2024-09

2. Management of Pheochromocytomas and Paragangliomas;Surgical Clinics of North America;2024-08

3. Personalized management for phaeochromocytomas and paragangliomas in Latin America: A genetic perspective;Best Practice & Research Clinical Endocrinology & Metabolism;2024-08

4. Medical Treatment of Malignant Pheochromocytoma;Updates in Surgery;2024-07-25

5. Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statement;Nature Reviews Endocrinology;2023-12-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3